Under neutropenic condition, as observed in cancer patients upon chemotherapy and radiotherapy [18], when patients are administered the growth factor granulocyte colony-stimulating factor (G-CSF), it can stimulate the de novo neutrophil generation via bone marrow hematopoiesis [19]. This evidence concerns the gene CSF3 and cancer.